Cortexyme Stock Price

0.34 (1.07%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Cortexyme Inc CRTX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.34 1.07% 32.10 20:00:00
Open Price Low Price High Price Close Price Prev Close
31.70 31.2166 33.085 32.10 31.76
Bid Price Ask Price Spread News
31.00 35.90 4.90 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,894 122,805 $ 32.21 $ 3,955,600 297,987 22.21 - 73.84
Last Trade Time Type Quantity Stock Price Currency
16:56:50 3 $ 31.90 USD

Cortexyme Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 946.89M 29.50M 15.45M $ - $ - -1.51 -13.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 3.50k 2.50%

more financials information »

Cortexyme News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CRTX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week32.5533.7930.6732.23174,587-0.45-1.38%
1 Month29.4333.7926.661230.07171,8762.679.07%
3 Months50.1958.9926.661236.11241,465-18.09-36.04%
6 Months44.0258.9926.661240.18154,052-11.92-27.08%
1 Year58.4573.8422.2143.51148,931-26.35-45.08%
3 Years20.0073.8419.3541.90134,39412.1060.5%
5 Years20.0073.8419.3541.90134,39412.1060.5%

Cortexyme Description

Cortexyme Inc is a clinical-stage biopharmaceutical company developing a disease-modifying therapeutic approach to treat Alzheimer's and other degenerative diseases. Its approach is based on the seminal discovery of the presence of Porphyromonas gingivalis or P. gingivalis, and its secreted toxic virulence factor proteases called gingipains. The company operates in only one reportable segment that is developing and commercializing therapeutics.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.